Literature DB >> 8615662

Potentiation of radiotherapy by nontoxic pretreatment with combined vitamins C and K3 in mice bearing solid transplantable tumor.

H S Taper1, A Keyeux, M Roberfroid.   

Abstract

BACKGROUND: The effect of intraperitoneal and oral pretreatment with combined vitamins C and K3 on the single dose radiotherapy of a transplantable solid mouse tumor have been investigated.
MATERIALS AND METHODS: Groups of mice bearing intramuscularly transplanted liver tumors, were orally and parenterally pretreated with combined vitamins C and K3 and locally irradiated with single doses of 20, 30, or 40 Gy of X-rays. After this treatment tumor dimensions were measured twice weekly and the approximate tumor volume in groups of pretreated vitamins and irradiated mice was compared to the groups of mice only irradiated and to the absolute control groups without any therapy.
RESULTS: This nontoxic pretreatment produced statistically significant potentiation of radiotherapy induced by 20 to 40 Gy of X-rays doses in groups of 11 to 20 mice. Combined vitamins C with K3 most probably constitute a redox-cycling system producing hydrogen peroxide and other active oxygen species to which cancer cells are selectively sensitive due to their frequent deficiency in enzymatic defense system against free oxyradicals agression.
CONCLUSIONS: A possible introduction of such nontoxic and selective potentiation procedure into classical protocols of human cancer therapy appears to be generally accessible and without any additional risk for patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8615662

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Serum markers variation consistent with autoschizis induced by ascorbic acid-menadione in patients with prostate cancer.

Authors:  Eduardo Lasalvia-Prisco; Silvia Cucchi; Jesús Vázquez; Eduardo Lasalvia-Galante; Wilson Golomar; William Gordon
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

2.  Pankiller effect of prolonged exposure to menadione on glioma cells: potentiation by vitamin C.

Authors:  Marina F Vita; Nivedita Nagachar; Dimitrios Avramidis; Zahid M Delwar; Mabel H Cruz; Åke Siden; Kajsa M Paulsson; Juan Sebastian Yakisich
Journal:  Invest New Drugs       Date:  2010-07-13       Impact factor: 3.850

3.  Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours.

Authors:  J J Casciari; N H Riordan; T L Schmidt; X L Meng; J A Jackson; H D Riordan
Journal:  Br J Cancer       Date:  2001-06-01       Impact factor: 7.640

4.  Pharmacological doses of daily ascorbate protect tumors from radiation damage after a single dose of radiation in an intracranial mouse glioma model.

Authors:  Carole Grasso; Marie-Sophie Fabre; Sarah V Collis; M Leticia Castro; Cameron S Field; Nanette Schleich; Melanie J McConnell; Patries M Herst
Journal:  Front Oncol       Date:  2014-12-15       Impact factor: 6.244

5.  Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant.

Authors:  Rumiana Bakalova; Severina Semkova; Donika Ivanova; Zhivko Zhelev; Thomas Miller; Tsuguhide Takeshima; Sayaka Shibata; Dessislava Lazarova; Ichio Aoki; Tatsuya Higashi
Journal:  Oxid Med Cell Longev       Date:  2020-11-02       Impact factor: 6.543

Review 6.  High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer.

Authors:  Franziska Böttger; Andrea Vallés-Martí; Loraine Cahn; Connie R Jimenez
Journal:  J Exp Clin Cancer Res       Date:  2021-10-30

7.  Targeting Glioblastoma via Selective Alteration of Mitochondrial Redox State.

Authors:  Akira Sumiyoshi; Sayaka Shibata; Zhivko Zhelev; Thomas Miller; Dessislava Lazarova; Ichio Aoki; Takayuki Obata; Tatsuya Higashi; Rumiana Bakalova
Journal:  Cancers (Basel)       Date:  2022-01-19       Impact factor: 6.639

8.  Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients.

Authors:  Nina Mikirova; Joseph Casciari; Neil Riordan; Ronald Hunninghake
Journal:  J Transl Med       Date:  2013-08-15       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.